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Abstract Fluorescence titrations showed that high-molecular- 
weight kininogen binds two molecules of papain, cruzipain and 
cathepsin S with high affinity. The 2:1 binding stoichiometry was 
confirmed by stopped-flow kinetic measurements of papain 
binding, which also revealed that the two sites bind the enzyme 
with different association rate constants (kas~,l = 23.0 X 106 M -1 
s -1 and k~,2 = 3.4 X 106 M -1 s -1 ). As for low-molecular-weight 
kininogen, comparison of these kinetic constants with previous 
data for intact low- and high-molecular-weight kininogen and 
the separated domains indicated that the faster-binding site is 
also the tighter-binding site and is that of domain 3, whereas the 
slower-binding, lower-affinity site is on domain 2. The results 
further demonstrate that there is no appreciable steric inter- 
ference between the two domains or by the kininogen light chain 
in the binding of proteinases. Similarly, the binding of kininogen 
via its light chain to a surface, as indicated by the binding to the 
model surface, heparin, did not affect the inhibitory properties of 
kininogen. The M~ of high-molecular-weight kininogen was 
determined to be 83 500 by sedimentation equilibrium measure- 
ments, in agreement with the value calculated from amino acid 
sequence and carbohydrate analysis. 
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disulfide bond, by limited proteolysis by kallikreins, thereby 
releasing the kinin segment [2]. The heavy chains of HK and 
LK are identical, whereas the light chain of HK is substan- 
tially larger than that of LK [8]. 
About a decade ago, kininogens were shown to be potent 
inhibitors of papain-like cysteine proteinases [9,10]. Structural 
analyses demonstrated that the kininogen heavy chain consists 
of three domains, designated D1-D3, which share a high in- 
ternal homology with low-molecular weight cystatins [2,11]. 
The kininogens therefore were classified as family 3 of the 
cystatin superfamily [12]. Isolated domains D2 and D3 were 
shown to inhibit papain-like cysteine proteinases (D2 and D3) 
and calpain (D2), whereas domain D1 was found to lack 
inhibitory activity [11,13]. 
We have recently shown that intact human LK simulta- 
neously can bind two molecules of cysteine proteinases with 
high affinity [14]. In this work we demonstrate hat human 
HK can also bind two molecules of cathepsin S, cruzipain and 
papain independently. Moreover, kinetic studies of papain 
binding showed that the two sites bound the proteinase with 
different rate constants. 
2. Materials and methods 
1. Introduction 
High-molecular-weight kininogen (HK) and low-molecular- 
weight kininogen (LK) are large multifunctional glycoproteins 
in mammalian plasma [1,2]. In addition, a third form of kini- 
nogens, T-kininogen (TK), has been identified in the rat and 
was found to be the major accute-phase protein in this species 
[3,4]. Kininogens have long been known as precursors of va- 
soactive peptides, the kinins. In addition, HK plays an im- 
portant role in the contact phase of blood coagulation [1,2], 
acts as an antagonist of thrombin-induced platelet aggrega- 
tion [5], and has been shown to bind to neutrophils [6]. 
Both human HK and LK are products of the same gene as 
a result of alternative mRNA splicing [7,8]. The originally 
single-chain proteins are easily converted to two-chain forms, 
consisting of a heavy and a light chain connected by a single 
*Corresponding author. Fax: (386) (61) 273 594. 
E-mail: boris.turk@ijs.si 
Abbreviations: -AMC, aminomethyl coumaryl amide; HK, high- 
molecular-weight kininogen; LK, low-molecular-weight kininogen; 
Z-, benzoyloxycarbonyl 
2.1. Materials 
Z-Phe-Arg-AMC was purchased from Serva (Heidelberg, Ger- 
many). Stock solutions of the substrate were prepared in dimethylsulf- 
oxide (Merck, Germany). Q Sepharose-Fast Flow and Superdex 200 
HR 10/30 columns were obtained from Pharmacia Biotech (Uppsala, 
Sweden). Chicken cystatin, bovine cathepsin S and cruzipain were 
purified as described previously [15-17]. Heparin, a gift from Dr. 
Steven T. Olson, University of Illinois at Chicago, had an average 
Mr of ~ 8000 and was similar to material used in a previous tudy 
[18]. Papain (2xcrystallized; Sigma, St. Louis, USA) was further 
purified by affinity chromatography [19]; the purified enzyme had a 
thiol content of 0.96 + 0.03 mol/mol protein. Papain was inactivated 
with methylmethanethiol sulfonate as described elsewhere [20]. The 
concentration f HK was determined from a molar absorbance oeffi- 
cient of 63 500, calculated from the amino acid sequence [8] according 
to the method of Pace et al. [21]. Concentrations of proteinases and of 
chicken cystatin were determined asdescribed previously [14]. 
2.2. Experimental conditions 
Unless otherwise stated, all experiments were performed at 250C in 
100 mM phosphate, 1.5 mM EDTA, pH 6.0. 
2.3. Purification of HK from human plasma 
HK and LK were purified from human plasma by a modification of
a previous procedure [22]. Plasma (500 ml) was exposed to pH 11.0 
for 30 rain, followed by acidification to pH 6.5 with acetic acid. A 
precipitate was removed by centrifugation at 10 000 z g for 15 rain. 
The supernatant was applied to a carboxymethyl-papain-Sepharose 
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4B column (200 ml [23]), equilibrated with 50 mM NH4OAc buffer, 
pH 6.5, containing 0.5 M NaCI. Unbound proteins were washed out 
with the same buffer, and the bound material was eluted with 10 mM 
NaOH. The inhibitory fractions were immediately neutralized with 
1 M NH4OAc buffer, pH 5.5, and were then concentrated and dia- 
lyzed against 20 mM Bis-Tris buffer, pH 6.5. The material was applied 
to a Q-Sepharose Fast Flow column (40x2.0 cm), equilibrated with 
the same buffer, and the column was washed extensively. Bound pro- 
teins were eluted with a 0-0.5 M NaC1 gradient (total volume 800 ml) 
in the same buffer, with a noninhibitory peak eluting at 0.1 M NaC1 
and LK and HK eluting at 0.25 and 0.32 M NaC1, respectively. The 
inhibitory fractions were pooled, concentrated and dialyzed against 
0.1 M acetate buffer, pH 5.5, containing 0.3 M NaC1. Minor impu- 
rities in the HK and LK preparations were removed by further pur- 
ification on a Superdex 200 HR 10/30 column, equilibrated in the 
same buffer. Final yields of 30 mg of LK and 15 mg of HK were 
obtained from 500 ml of plasma. 
2.4. Fluorescence titrations 
Fluorescence titrations of proteinases with chicken cystatin or HK 
were performed in an SLM 4800S spectrofluorimeter (SLM-Aminco, 
Urbana, IL, USA) as described previously [14]. The binding curves 
were analysed by non-linear least-squares computer fitting to the equi- 
librium binding equation [24]. 
2.5. Kinetic analyses 
The kinetics of inhibition of papain by HK were analysed in an SX- 
17MV stopped-flow apparatus (Applied Photophysics, Leatherhead, 
UK). The reactions were monitored either by the decrease in trypto- 
phan fluorescence mission accompanying the interaction or by the 
formation of fluorescent product released by the proteinase in experi- 
ments carried out in the presence of substrate, ssentially as described 
previously [14]. The association rate constant deterrninined from ex- 
periments in the presence of substrate was corrected for substrate 
competition with the use of a Km value of 65/.tM [25]. 
2.6. Analytical ultracentrifugation 
Sedimentation equilibrium measurements were conducted at 20°C 
in an MSE Centriscan analytical ultracentrifuge (MSE, Crawley, UK) 
and were monitored by photoelectric s anning [26]. The concentration 
of HK was 0.6 mg/ml. A partial specific volume of 0.695 ml/g was 
calculated for HK from the amino acid sequence and carbohydrate 
composition [8,27]. 
3. Results 
3.1. Binding stoichiometry by fluorescence titrations 
Titrations of fully active papain with chicken cystatin 
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Fig. 1. Fluorescence titrations of papain (O), cathepsin S (e) and 
cruzipain (m) with HK. The proteinase concentrations were 500 nM. 
Other experimental conditions were as described in Section 2. Ft, 
fluorescence of added HK; Fo, fluorescence of proteinase; F, fluor- 
escence of HK-proteinase mixture. Fitted curves were generated by 
nonlinear egression analysis [24]. 
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Fig. 2. Kinetics of binding of S-(methylthio)papain to HK. The de- 
crease in tryptophan fluorescence accompanying the interaction was 
monitored as described in Section 2. (a) Single-exponential progress 
curve for the reaction between 1 pM HK and 50 nM S- 
(methylthio)papain. (b) Double-exponential progress curve for the 
reaction between 1 I.tM S-(methylthio)papain d 50 nM HK. Both 
curves are shown with the best fit generated by nonlinear egression 
analysis. 
showed the inhibitor to be essentially 100% active in enzyme 
binding (inhibitor to enzyme binding stoichiometry 1.1). Ca- 
thepsin S and cruzipain were shown by similar titrations with 
chicken cystatin to be 80 and 70% active, respectively. The 
proteinases were then titrated with HK, demonstrating that 
0.50-0.56 mol of HK  were needed to saturate 1 mol of pro- 
teinase (Fig. 1). Computer fitting of the titration curves gave 
apparent proteinase to HK binding stoichiometries of 2.0, 1.9 
and 1.8 for papain, cathepsin S and cruzipain, respectively. 
The value for papain was shown to be independent of  protein- 
ase concentration in the range 0.1-1 IxM. The results thus 
indicate two binding sites for proteinases on each kininogen 
molecule. 
3.2. Kinetics of binding 
The kinetics of binding of HK  to papain were studied by 
two different methods. In one method, the reactions were 
monitored by the decrease in tryptophan fluorescence accom- 
panying the binding. The experiments were performed under 
pseudo-first-order conditions with a 20-fold molar ratio of 
proteinase to HK, enabling detection of proteinase binding 
to both inhibitory sites. Papain was inactivated with methyl- 
methanethiol sulfonate [20] before the analyses to prevent 
cleavage of HK  by excess proteinase and to increase the fluor- 
escence change [28]. This modification has been shown only 
minimally to affect the association rate constants for various 
cystatin-cysteine proteinase interactions [14,28]. The kinetics 
of papain binding to HK showed two phases and were best 
fitted to a double-exponential function (Fig. 2). The depen- 
dence of the observed pseudo-first-order rate constants for the 
two phases on the papain concentration was linear for both 
phases up to the highest concentration used (16/.tM; Fig. 3a). 
Second-order association rate constants of 23.0-+0.9x 106 
M -1 s -1 and 3.4_+0.1× 106 M -1 s -1 were calculated for the 
two phases from the slopes of these lines. The amplitude ratio 
of the two phases was 0.90 + 0.07. 
Since HK is known to bind to surfaces via its light chain 
(reviewed in [1]), we investigated the effect of such binding on 
the inhibitory properties of the protein, using heparin as a 
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Fig. 3. (a) Dependence of the rate constants of the slow (e) and 
fast (©) phases on S-(methylthio)papain binding to HK (see Fig. 2) 
on proteinase concentration. (b) Dependence of the rate constant of 
HK binding to active papain on proteinase concentration i  experi- 
ments monitored in the presence of substrate, as described in Sec- 
tion 2. Solid lines in (a,b) were generated by linear regression analy- 
sis. 
model surface [29,30]. Heparin (final concentration 2 gM) was 
incubated with HK (final concentration 100 riM) for 20 min 
and the kinetics of papain binding were then analysed as 
described above. Identical kinetic behaviour was observed in 
the absence and presence of heparin. 
In a further experiment, also employing analysis by trypto- 
phan fluorescence, a 20-fold molar ratio of HK to S- 
(methylthio)papain was used instead. In this case, monophasic 
kinetics were observed (Fig. 2), in contrast with the biphasic 
behaviour evident at an excess of S-(methylthio)papain. How- 
ever, both the observed pseudo-first-order rate constant (37.9 
s -1) and the amplitude (0.073 V) obtained in this manner at 
1 gM HK were in good agreement with the corresponding 
values for the faster process determined at 1 gM S- 
(methylthio)papain with an excess of the latter (32.2 s 1, 
0.075 V). These results strongly suggest hat at an excess of 
HK the proteinase binds predominantly to the faster-binding 
site, whereas the slower-binding site remains largely unoccu- 
pied. 
In the second kinetic method, a fluorescent substrate was 
used to monitor papain activity. The experiments were carried 
out under pseudo-first-order conditions with a 10-fold molar 
ratio of HK to papain, which precluded etermination of the 
association rate constant for the slower-binding site (see 
above). All progress curves had a final slope of zero, showing 
that the reactions were essentially irreversible at the inhibitor 
concentrations used, and were thus fitted to a simple expo- 
nential function [31]. The plot of the observed pseudo-first- 
order rate constant vs. HK concentration was linear and gave 
an association rate constant of 33.3 + 1.1 x 106 M -1 s -1 after 
correction for substrate competition. This value is similar to 
that determined for the binding of S-(methylthio)papain to 
the faster binding site of HK, in agreement with results 
from analogous tudies of the LK/papain interaction [14]. 
The value also agrees well with values of 14-30x 106 M -1 
s -1 determined previously for the HK/papain interaction [32]. 
3.3. Molecular weight determination by ultracentrifugation 
An Mr of 83 500 + 4000 was determined for HK by sedi- 
mentation equilibrium measurements. This value is in reason- 
able agreement with that of 91 000 calculated from the amino 
acid sequence [8] and carbohydrate analysis [27], but lower 
than the value of 110000 estimated by SDS-PAGE (reviewed 
in [1,2]). This difference indicates that HK behaves anoma- 
lously in SDS-PAGE, probably due to the glycosylation of the 
molecule. 
4. Discussion 
We recently showed that intact LK simultaneously can bind 
two molecules of papain-like cysteine proteinases with high 
affinity [14]. As the light chain of HK is considerably larger 
than that of LK [8], it might be expected to interfere with 
proteinase binding to the HK heavy chain. However, we dem- 
onstrate here that human HK can also simultaneously bind 
two molecules of papain-like cysteine proteinases. This con- 
clusion is apparent from fluorescence titrations of enzymes 
with carefully standardized concentrations and from 
stopped-flow kinetic analyses of the papain-HK interaction. 
It has been shown previously that the free kininogen do- 
mains, isolated by proteinase digestion or expressed in bacter- 
ia, differ both in the kinetics and affinities of binding of target 
proteinases. Free domain 3 thus binds the enzymes 1-3 orders 
of magnitude faster and tighter than domain 2, depending on 
the proteinase [11,13,33,34]. Our previous work showed that 
the rate constants for proteinase binding to the individual 
domains of intact LK differ significantly, with the values 
(0.8-1.4X106 M -1 s -1 for domain 2 and 11-24×106 M -1 
s -1 for domain 3 [14]) being close to those determined for 
isolated domains 2 and 3. It was therefore concluded that 
the faster-binding site in intact LK is the site located in do- 
main 3, whereas the slower-binding site is that of domain 2 
[14]. The comparable kinetics of papain binding to HK as to 
LK shown here leads to the same assignment for the two 
proteinase-binding domains of HK. However, the rate con- 
stant for the slower reaction was ,~2.5-fold higher for HK 
(3.4 X 106 M -1 s -1) than for LK, indicating a small, possibly 
conformational, effect of the HK light chain on the binding of 
proteinases to domain 2. Nevertheless, the results show that 
there is no major steric hindrance for proteinase binding to 
individual domains of HK or LK, either by the adjacent do- 
mains or by the light chain. Moreover, the binding of the light 
chain of HK to a surface, as exemplified by binding to heparin 
in this work, similarly does not appear to affect the inhibitory 
properties of the individual domains of HK. 
The kininogens are the major physiological plasma inhibi- 
tors of cysteine proteinases, due to their high concentration i  
plasma [35] and high affinity for such proteinases. Under nor- 
112 
real conditions, target enzymes are inactivated mainly by 
binding to domain 3 of both HK, as shown here, and LK 
[14]. Under certain circumstances domain 2 may serve to en- 
hance inhibitory capacity of both kininogens and also func- 
tions by binding calpain [11]. However, the possible functional 
significance of the tandem arrangement of inhibitory domains 
in the kininogen heavy chain remains unclear. 
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